Wei Fu
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
-
- Epigenetics and DNA Methylation 3
-
- COVID-19 Clinical Research Studies 3
- Co-authors
- Weihong Zhu (2 shared papers)Chenxu Yan (2 shared papers)Zhiqian Guo (2 shared papers)He Tian (2 shared papers)Jingjing Zhang (1 shared paper)Haiyan Zhang (1 shared paper)Mübeccel Akdiş (2 shared papers)Jinjin Zhang (2 shared papers)
- Journals
- PLoS ONE (2 papers)Scientific Reports (2 papers)Frontiers in Psychiatry (2 papers)BMC Gastroenterology (2 papers)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- ChinaSwitzerlandUnited States
In The Last Decade
Wei Fu
30 papers receiving 1.8k citations
Wei Fu's Hit Papers
Peers
Comparison fields: 5 of 133
- Infectious Diseases 614
- Neurology 306
- Spectroscopy 210
- Modeling and Simulation 46
- Obstetrics and Gynecology 72
Countries citing papers authored by Wei Fu
This map shows the geographic impact of Wei Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Fu more than expected).
Fields of papers citing papers by Wei Fu
This network shows the impact of papers produced by Wei Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Fu. The network helps show where Wei Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Risk factors for severe and critically ill COVID‐19 patients: A review Hit paper breakdown → | 2020 | 850 |
| 2 | Rational Design of Near-Infrared Aggregation-Induced-Emission-Active Probes: In Situ Mapping of Amyloid-β Plaques with Ultrasensitivity and High-Fidelity Hit paper breakdown → | 2019 | 398 |
| 3 | 2011 | 96 | |
| 4 | 2023 | 72 | |
| 5 | 2012 | 67 | |
| 6 | 2020 | 66 | |
| 7 | 2011 | 55 | |
| 8 | 2017 | 44 | |
| 9 | 2017 | 27 | |
| 10 | 2019 | 23 | |
| 11 | 2014 | 19 | |
| 12 | 2017 | 14 | |
| 13 | 2021 | 11 | |
| 14 | 2021 | 10 | |
| 15 | 2010 | 10 | |
| 16 | 2019 | 10 | |
| 17 | 2016 | 9 | |
| 18 | 2020 | 8 | |
| 19 | 2020 | 8 | |
| 20 | 2011 | 8 |
About Wei Fu
Wei Fu is a scholar working on Molecular Biology, Infectious Diseases, Epidemiology, Oncology and Surgery, having authored 36 papers that have together received 1.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers), MicroRNA in disease regulation (3 papers), Substance Abuse Treatment and Outcomes (3 papers), Epigenetics and DNA Methylation (3 papers), COVID-19 Clinical Research Studies (3 papers), Macrophage Migration Inhibitory Factor (2 papers) and Piperaceae Chemical and Biological Studies (2 papers). The work is most often cited by research in Infectious Diseases (614 citations), Neurology (306 citations), Spectroscopy (210 citations), Modeling and Simulation (46 citations) and Obstetrics and Gynecology (72 citations). Wei Fu has collaborated with scholars based in China, Switzerland and United States. Frequent co-authors include Weihong Zhu, Chenxu Yan, Zhiqian Guo, He Tian, Jingjing Zhang, Haiyan Zhang, Mübeccel Akdiş, Jinjin Zhang, Ahmet Kürşat Azkur and Milena Sokołowska. Their work appears in journals such as PLoS ONE, Scientific Reports, Frontiers in Psychiatry, BMC Gastroenterology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.